Segment Reporting - Revenues (Details) - USD ($) $ in Thousands	3 Months Ended
	Jun. 03, 2023	May 28, 2022
Segment Reporting
Revenues	$ 5,653,162	$ 6,014,583
Gross Profit	1,178,526	1,196,729
Adjusted EBITDA	91,715	100,130
Depreciation and amortization	65,895	70,073
LIFO charge	7,500
Stock-based compensation expense	1,081	3,334
Additions to property and equipment and intangible assets	47,503	85,424
Retail Pharmacy Segment
Segment Reporting
Revenues	4,492,329	4,345,356
Operating Segments | Retail Pharmacy Segment
Segment Reporting
Revenues	4,492,329	4,345,356
Gross Profit	1,086,863	1,097,357
Adjusted EBITDA	70,049	73,682
Depreciation and amortization	55,469	56,108
LIFO charge	7,500
Stock-based compensation expense	723	3,102
Additions to property and equipment and intangible assets	40,439	78,551
Operating Segments | Pharmacy Services Segment
Segment Reporting
Revenues	1,196,154	1,725,857
Gross Profit	91,663	99,372
Adjusted EBITDA	21,666	26,448
Depreciation and amortization	10,426	13,965
Stock-based compensation expense	358	232
Additions to property and equipment and intangible assets	7,064	6,873
Intersegment elimination
Segment Reporting
Revenues	$ (35,321)	$ (56,630)